|
46 Companies |
|
12 Products |
|
12 Products |
|
17 Mechanisms of Action |
|
756 Trials |
|
22406 News |
|
| «12...389390391392393394395396397398399...401402» |
- | Trial primary completion date: Role of MicroRNAs on Age and Contraction-induced Skeletal Muscle Growth (clinicaltrials.gov) - Sep 7, 2017
P=N/A, N=30, Recruiting, Sponsor: Tufts University
Trial primary completion date: Apr 2017 --> Sep 2017
- | Trial primary completion date: ExPrEs: Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes (clinicaltrials.gov) - Aug 28, 2017
P=N/A, N=60, Recruiting, Sponsor: University of Maryland
Trial primary completion date: Apr 2017 --> Sep 2017 Trial primary completion date: Jul 2017 --> Jul 2018
- | New trial: Exercise and Nutrition to Improve Pancreatic Cancer Outcomes (clinicaltrials.gov) - Aug 21, 2017
P=N/A, N=60, Recruiting, Sponsor: University of Oklahoma
- | New trial: Bone Microstructure by Using HR-pQCT in Long Courses After Gastrectomy (clinicaltrials.gov) - Aug 15, 2017
P=N/A, N=114, Recruiting, Sponsor: Kobayashi Shinichiro
- | Humalog pen (insulin lispro) / Eli Lilly
New trial: Effects of Insulin on Hypotension and Sarcopenia (clinicaltrials.gov) - Aug 13, 2017
P=N/A, N=30, Not yet recruiting, Sponsor: Kenneth Madden
- | Trial completion, Trial primary completion date: Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults (clinicaltrials.gov) - Aug 8, 2017
P=N/A, N=72, Completed, Sponsor: Mayo Clinic
Trial primary completion date: Jul 2017 --> Jul 2018 Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> May 2016
- ||| Enrollment open: An OBServational Clinical Trial (SARA-OBS) in Sarcopenia and Sarcopenic Obesity in Patients Aged 65 Years and Over (clinicaltrials.gov) - Jul 31, 2017
P=N/A, N=300, Recruiting, Sponsor: Biophytis
Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> May 2016 Not yet recruiting --> Recruiting
- | New trial: Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation (clinicaltrials.gov) - Jul 31, 2017
P=N/A, N=24, Recruiting, Sponsor: University of Roma La Sapienza
- | Enrollment open: SARCSA: Validation of a Screening Test for Sarcopenia in Older People (clinicaltrials.gov) - Jul 26, 2017
P=N/A, N=1300, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Enrollment change: A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study (clinicaltrials.gov) - Jul 25, 2017
P2, N=200, Recruiting, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Recruiting N=125 --> 200
- | Trial completion, Enrollment change, HEOR: Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy (clinicaltrials.gov) - Jul 25, 2017
P=N/A, N=40, Completed, Sponsor: Brazilian National Cancer Institute
N=125 --> 200 Recruiting --> Completed | N=60 --> 40
- | Trial primary completion date: Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=135, Recruiting, Sponsor: Chinese University of Hong Kong
Recruiting --> Completed | N=60 --> 40 Trial primary completion date: Feb 2017 --> Sep 2017
- | Enrollment change: Preventive Physiotherapy Intervention in Elderly People With Sarcopenia (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=91, Completed, Sponsor: University of Valencia
Trial primary completion date: Feb 2017 --> Sep 2017 N=70 --> 91
- | New trial: WAVE Study- Walking and Aging in VErona Study (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=64, Recruiting, Sponsor: Azienda Ospedaliera Universitaria Integrata Verona
- | Trial completion, Enrollment change: The Strong Brain Study (clinicaltrials.gov) - Jul 6, 2017
P=N/A, N=18, Completed, Sponsor: University of Florida
N=70 --> 91 Recruiting --> Completed | N=40 --> 18
- | Trial completion, Phase classification, Trial primary completion date: Carnitine Supplementation and Skeletal Muscle Function (clinicaltrials.gov) - Jul 5, 2017
P1/2, N=40, Completed, Sponsor: Gdansk University of Physical Education and Sport
Recruiting --> Completed | N=40 --> 18 Active, not recruiting --> Completed | Phase classification: P2/3 --> P1/2 | Trial primary completion date: Feb 2017 --> Jul 2017
- || Trial primary completion date: Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2 (clinicaltrials.gov) - Jun 27, 2017
P1, N=160, Recruiting, Sponsor: Metabolic Technologies Inc.
Active, not recruiting --> Completed | Phase classification: P2/3 --> P1/2 | Trial primary completion date: Feb 2017 --> Jul 2017 Trial primary completion date: Dec 2017 --> Jul 2018
- ||| bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Enrollment change, Trial primary completion date: A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study (clinicaltrials.gov) - Jun 26, 2017
P2, N=125, Recruiting, Sponsor: Novartis Pharmaceuticals
Trial primary completion date: Dec 2017 --> Jul 2018 N=240 --> 125 | Trial primary completion date: Feb 2018 --> Sep 2018
- | New trial: SARCSA: Validation of a Screening Test for Sarcopenia in Older People (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=1300, Not yet recruiting, Sponsor: University Hospital, Clermont-Ferrand
- | New trial: MQS: Effects of Mobility Dose in Surgical Intensive Care Unit Patients (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=150, Recruiting, Sponsor: Massachusetts General Hospital
- | Enrollment open, Enrollment change: POWR-UP: A High Protein Weight Loss Intervention for Sarcopenic Obesity in Women (clinicaltrials.gov) - Jun 20, 2017
P=N/A, N=110, Recruiting, Sponsor: Duke University
N=240 --> 125 | Trial primary completion date: Feb 2018 --> Sep 2018 Active, not recruiting --> Recruiting | N=80 --> 110
- | Enrollment status: TDAP2: Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults (clinicaltrials.gov) - Jun 15, 2017
P=N/A, N=50, Enrolling by invitation, Sponsor: VA Office of Research and Development
Active, not recruiting --> Recruiting | N=80 --> 110 Recruiting --> Enrolling by invitation
- | Enrollment open: Improving Rehabilitation In Sarcopenia (IRIS) (clinicaltrials.gov) - Jun 7, 2017
P=N/A, N=140, Recruiting, Sponsor: Azienda di Servizi alla Persona di Pavia
Recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
- | New trial: Guangzhou Nutrition and Health Study (GNHS) (clinicaltrials.gov) - Jun 7, 2017
P=N/A, N=4540, Active, not recruiting, Sponsor: Sun Yat-sen University
- | Biomarker, New trial: SleSOB: Sleep Disturbances and Biomarkers of Sarcopenic OBesity (clinicaltrials.gov) - Jun 5, 2017
P=N/A, N=100, Not yet recruiting, Sponsor: Istituto di Fisiologia Clinica CNR
- | Enrollment open: Identifying Therapeutic Targets of Accelerated Sarcopenia (clinicaltrials.gov) - May 31, 2017
P=N/A, N=102, Recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Enrollment open: Microbiome and Sarcopenia in Patients With Liver Cirrhosis (clinicaltrials.gov) - May 30, 2017
P=N/A, N=120, Recruiting, Sponsor: Medical University of Graz
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | New trial: PRESAR-HF: Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before TAVI (clinicaltrials.gov) - May 15, 2017
P=N/A, N=300, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- | Enrollment closed, Trial primary completion date: Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease? (clinicaltrials.gov) - May 12, 2017
P=N/A, N=565, Active, not recruiting, Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Apr 2018
- | Trial completion: Semi-Recumbent Vibration Therapy in Older Adults (clinicaltrials.gov) - May 12, 2017
P=N/A, N=32, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Apr 2018 Recruiting --> Completed
- | Novolin R (recombinant human insulin) / Novo Nordisk
Trial primary completion date: Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle (clinicaltrials.gov) - May 11, 2017
P=N/A, N=32, Enrolling by invitation, Sponsor: University of Nottingham
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Apr 2018
- | New trial: Post - Hospital Syndrome: Profile of Functional Status by Malnutrition (clinicaltrials.gov) - May 9, 2017
P=N/A, N=200, Recruiting, Sponsor: Charite University, Berlin, Germany
- | Enrollment closed, Phase classification: Effect of Creatine Supplementation and Exercise on Bone Health (clinicaltrials.gov) - May 5, 2017
P=N/A, N=240, Active, not recruiting, Sponsor: University of Saskatchewan
Trial primary completion date: Jun 2016 --> Apr 2018 Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A
- | New trial, HEOR: PROT-HF: Effect of Whey Protein' Supplementation and Exercise in Patients With Heart Failure (clinicaltrials.gov) - May 5, 2017
P=N/A, N=4, Recruiting, Sponsor: National Institute of Cardiology, Laranjeiras, Brazil
- Phase classification: The Effect of Bovine Colostrum Supplementation in Older Adults (clinicaltrials.gov) - May 4, 2017
P=N/A, N=40, Completed, Sponsor: University of Saskatchewan
Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A Phase classification: P3 --> P=N/A
- | sirolimus / Generic mfg.
Phase classification: Nutritional and Contractile Regulation of Muscle Growth (clinicaltrials.gov) - May 4, 2017
P1, N=144, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Phase classification: P3 --> P=N/A Phase classification: P=N/A --> P1
- | Enrollment open, Trial initiation date: Exercise Intervention in Liver Transplant Patients (clinicaltrials.gov) - May 3, 2017
P=N/A, N=500, Recruiting, Sponsor: University of California, San Francisco
Phase classification: P=N/A --> P1 Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Jul 2016
- | New trial: eHIT: HIT Training in the Frail Elderly. (clinicaltrials.gov) - May 3, 2017
P=N/A, N=34, Recruiting, Sponsor: University of Nottingham
- | Trial completion: FRANSO: Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+ (clinicaltrials.gov) - May 2, 2017
P3, N=100, Completed, Sponsor: University of Erlangen-N
Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Jul 2016 Active, not recruiting --> Completed
- | Enrollment open: Roles of Uremic Toxins in Uremic Sacropenia (clinicaltrials.gov) - Apr 26, 2017
P=N/A, N=300, Recruiting, Sponsor: Tungs
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Trial primary completion date: MM-DC: Estimation of Muscle Mass in Older Adults Using Deuterated Creatine (clinicaltrials.gov) - Apr 24, 2017
P=N/A, N=62, Recruiting, Sponsor: University Hospital, Toulouse
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2016 --> Mar 2018
- | New trial: Post - Hospital Syndrome: Profile of Functional Status by Malnutrition (clinicaltrials.gov) - Apr 24, 2017
P=N/A, N=185, Recruiting, Sponsor: Charite University, Berlin, Germany
- | Biomarker, New trial: The Study of Sarcopenia and Aging Biomarkers by the Metabolomics (clinicaltrials.gov) - Apr 20, 2017
P=N/A, N=650, Recruiting, Sponsor: Chang Gung Memorial Hospital
- | New trial: Improving Rehabilitation In Sarcopenia (IRIS) (clinicaltrials.gov) - Apr 19, 2017
P=N/A, N=140, Not yet recruiting, Sponsor: Azienda di Servizi alla Persona di Pavia
- | Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
New P1/2 trial: INOSO: The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity (clinicaltrials.gov) - Apr 17, 2017
P1/2, N=36, Not yet recruiting, Sponsor: Sara Espinoza
- | New trial: SARCOBS: Sarcopenia in COPD Patients: a French Study (clinicaltrials.gov) - Apr 13, 2017
P=N/A, N=50, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- | New trial: Mechanisms of Age-Related Muscle Loss (clinicaltrials.gov) - Apr 13, 2017
P=N/A, N=38, Completed, Sponsor: University of Birmingham
- | Trial primary completion date: Association Between Different Parameters of Nutritional Assessment and Clinical Outcomes in Cancer Patients (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=120, Active, not recruiting, Sponsor: Federal University of Minas Gerais
Trial primary completion date: Mar 2016 --> Mar 2018 Trial primary completion date: Jul 2016 --> Mar 2017
- Trial primary completion date: PRIMe: Protein Recommendation to Increase Muscle (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=36, Recruiting, Sponsor: University of Alberta
Trial primary completion date: Jul 2016 --> Mar 2017 Trial primary completion date: Apr 2018 --> Dec 2018
- | Enrollment open: Lysosomal Movement and Anabolic Resistance (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=26, Recruiting, Sponsor: University of Birmingham
Trial primary completion date: Apr 2018 --> Dec 2018 Not yet recruiting --> Recruiting